ICT meets BioWin - Présentation générale
44
ICT meets BioWin « Les TIC au cœur de la biotechnologie! » Rencontres INFOPOLE Cluster TIC – Pôle BioWin - Agoria BEP Namur – 16 décembre 2014
-
Upload
infopole-cluster-tic -
Category
Technology
-
view
96 -
download
4
Transcript of ICT meets BioWin - Présentation générale
ICT meets BioWin« Les TIC au cœur de la biotechnologie! »
Rencontres INFOPOLE Cluster TIC – Pôle BioWin - Agoria
BEP Namur – 16 décembre 2014
Programme• 14.00 : Bienvenue
• 14.10 : Les enjeux du secteur TIC et de la santé pour répondre aux besoins du patient
• 14.20 : Les TIC au coeur de la biotechnologie
• 16.00 : Débat avec les orateurs
• 16.30 : Break
• 17.00 : Présentations “pitch”
• 18.00 : Cocktail networking de fin d’année de l’INFOPOLE Cluster TIC
BIOWINECOSYSTEMKEY FIGURESACTIVITIESTECHNOLOGICAL AREAS
Rencontre Infopole Cluster TIC, BioWin et Agoria
16 dec 2014
BIOWIN THE HEALTH CLUSTER OF WALLONIA
Field (red biotechnology)
-Health biotechnology
-Medical technology
- Human and animal
Définition de l’OCDE des biotechnologies : « l’application des principes scientifiques et de l'ingénierie à la transformation dematériaux par des agents biologiques pour produire des biens et services »
BIOWIN THE HEALTH CLUSTER OF WALLONIA
BioWin has more than 510 members gathering• 130 innovative companies.• 6 global leaders
• 400 research units from 5 universities
• 11,000 researchers• 10 000 hospital beds (EU leader in clinical trials phase I)• Prestigious Research Institutes
the GIGA (Liège), the Institute of Medical Immunology (IMI) or the Christian De Duve Institute of Cellular Pathology
BIOWIN THE HEALTH CLUSTER OF WALLONIA
BioWin has more than 510 members gathering• Private Research Centres
• Specific infrastructures (specialized incubators & High Tech Platforms)
BIOWIN THE HEALTH CLUSTER OF WALLONIA
A region at the very heart of Europe with a strong network. 1 hour drive between the clusters partners.
Population: 3.4 MillionSurface: 17,000 Km²
Innovative companies
FACTS & FIGURES
Companies
•Direct jobs (2014): 16,000 (+ 32,000 indirect jobs = total jobs 48,000)
•R&D investments (2013) : Euros 1.05 billion
•Pharma/Biopharma = 25% of total Wallonia export
Source : Essenscia Wallonie, AWEX
EMPLOYMENT IN BIOWIN MEMBERS ENTERPRISES
2005 2006 2007 2008 2009 2010 2011 20120
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
9,255
11,022
12,293
13,588 13,78714,302
15,06115,807
71 % growth rate over 8 years!
2005 2006 2007 2008 2009 2010 2011 20120
500
1,000
1,500
2,000
2,500
1,367
1,585
1,748
1,9352,027
2,099
2,2532,308
262329
389 426 454511
584639
96 SME
35 SMEs involved in a Biowin project
EMPLOYMENT IN BIOWIN SME MEMBERS (FTE)
69% growth over 8 years
144% growth over 8 years
BIOWIN’S CORE ACTIVITIES
REGIONAL ECONOMIC DEVELOPMENT THROUGH CLUSTERS POLICY
BioWin major achievements 2006-2014
Þ32 collaborative R&D projects for a total (public-private) budget of Euros 99 millions
Þ contribution to the creation of 5 new companies (iTeos, Imcyse, MaSTherCell, CluePoints, DNAlytics)
Þ launch of 14 new products and services on the market
Þ 80 patents
Þ Partnership with the Massachusetts Life Sciences Center
Þ Strategic training initiatives (incl. BioPhare, Strategio)
Þ 3 new collaborative platforms (MastherCell, Protontherapy, biobank)
About 1,500 jobs to be created in the 5 years post-projects
KEY TECHNOLOGICAL AREASIN WALLONIA
Know more about BioWin membersDiscover our specific technological brochures & our online Members Directory!
REGENERATIVE MEDICINE & CELL THERAPY
An industrial excellence and a fully integrated value chain
(ATMP CDMO)
(CMO)
(Phase III)
(Phase II)
(Phase III)
(Preclinical)
(Phase II)
R&D Preclinical
Clinical Research
Product Development Production
Regulatory Marketing
SalesBiologistics
30 research labs5 cell therapy companiesSupport expertise and biomaterials
Discover our specific technological brochure!
IN VITRO DIAGNOSTICS
Biomarkers identification & diagnostics tools development
R&D PreclinicalClinical Validation
Product DevelopmentProduction
Regulatory Marketing
Sales
Academia & Research centers
Technological support
Discover our specific technological brochure!
INSTRUMENTS & MEDICAL DEVICES
R&D Product Development/
ValidationsProduction
Contact BioWin
R&D
Sylvie PonchautDeputy Director & R&D Director [email protected]
Marianne Ghyoot Associate Dir R&[email protected]
Thierry FerainR&D Portfolio [email protected]
International
Laurence TimmermansInnovation and technological [email protected]
Visit our website : www.biowin.org
Follow us!
Blog Win-Health.org Linkedin
Twitter (@BioWin_asbl)
IMMUNOLOGY
Immunotherapy
In Vitro Diagnostics (inflammatory & infectious diseases)
Basic/Applied - Clinical research
Drug/Vaccines development
RADIATION APPLICATIONS IN HEALTHCARE
Related activities
WWW.RAD4MED.BE
BIOTECHNOLOGY PRODUCTS AND SERVICES
CRO
IT support
And many others…
CMO
INFOPOLE Cluster TIC – Qui sommes nous?Cluster privé
150 membres dont 127 entreprises
Financement 50% par le public (reconnaissance cluster du décret Wallon)
Label international « Bronze » par la Commission Européenne
Basé à Namur mais qui couvre toute la Wallonie
Une des pièces du Puzzle du secteur TIC Wallon
Quelle pièce du puzzle?
La formation
La demande
La recherche
Evolution d’une entreprise
Et les multi-sectoriels et/ou régionalistes
Nos membres
Nos membres
9%
11%
12%
13%
17%
18%
21%
Cryptographie, gestion de la sécurité Solutions VoIP, outils collaboratifsHosting, Grid- and Cloud-computing, virtualisation Equipements et Services réseauxApplications mobiles, embarquées et systèmes intelligents Dev Logiciels - Web, portails, marketing et communicationDev Logiciels - Application multi-tiers / métiers
10 % actifs dans l’e-health
Secteurs d’activité
Les enjeux du secteur TIC et de la santé pour répondre aux besoins du patient
Mme. Carole Absil, Agoria
Les TIC au coeur des la biotechnologie
• LOGIC-insulin, Algorithm-Guided Versus Nurse-Directed
Blood Glucose Control – M. Tom VAN HERPE, Katholieke Universiteit Leuven
• Big Data in Biotechnologies – M. Bart VANNIEUWENHUYSE, Janssen
• Regenerative Medicine for Bone Diseases – Mme Julia INO, Bone
Therapeutics
Les TIC au coeur des la biotechnologie
• D’une nouvelle génération d’implant ophtalmique à la télémédecine
M. Michel VAN BRABANT, iSTAR Medical
• Easy Move au service de la performance sportive et de la santé
Mme. Anne-Marie CLARINVAL, Human Waves
• Next Generation DNA sequencing applied to routine cancer care M.
Jean-Paul DETIFFE, OncoDNA
Place au débat!
Place aux pitches!
Remerciements
Place aux rencontres !
